Rucaparib: A white to pale yellow powder

Marykudro08 Jun, 2022Health

Healthcare professionals use the drug Rucaparib in the treatment of patients who have advanced ovarian and prostate cancers. Rucaparib is an inhibitor of poly polymerase enzymes, including PARP-1, PARP-2, and PARP-3, which play a role in DNA repair. Clinical studies have shown that rucaparib-induced cytotoxicity might involve inhibition of PARP enzymatic activity and increased formation of PARP-DNA complexes resulting in DNA damage, apoptosis, and cancer cell death. Rucaparib tablets come in the strengths of 200 mg and 300 mg to administer orally. The common side-effects of Rucaparib have increased levels of creatinine, nausea, low red blood cell counts, tiredness or weakness, liver enzymes in the blood, low levels of platelets, decreased appetite, taste disturbances, vomiting, diarrhea, and belly ache. Rucaparib tablets are readily available from several generic medicine suppliers. For more information on Rucaparib, reach us on 18008891064.